High Times – by Maureen Meehan
At the turn of the century, before the Marihuana Tax Act of 1937, Eli Lilly, Parke-Davis and Squibb of Bristol-Myers Squibb, were marketing cannabis extracts and tinctures labeled as “uniformly effective at dose levels of 10 mg.”
In those days, most medicines had the same generic characteristics, so drug companies had to rely on marketing and brand recognition to sell their products. Continue reading “Big Pharma Companies Were The Original Medical Pot Sellers”

BBC
Fox News
Fox News
Activist Post – by Jefferey Jaxen
RT
Sputnik
Press TV
Sent to us by a reader.
Huffington Post – by Lucy McCalmont
D.C. Clothesline
D.C. Clothesline
D.C. Clothesline
Freedom Outpost – by Michael Bastasch
ABC 6
The Daily Sheeple – by Melissa Melton